Atherosclerotic vascular disease

1 paper

Human trial1

Trial sponsors

Merck & Co.
Company1 trialPhase 183 people
Robert Rosenson
1 trialPhase 441 people
Montreal Heart Institute
1 trialPhase 2106 people

Latest

3 in 12 months

European Journal of Haematology31 Aug

Von Willebrand Factor and ADAMTS13 in Relation to Atherosclerosis in the General Population: The Rotterdam Study

Cohort study of 2,224 peopleAtherosclerosis

Circulation18 Aug

Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease: Insights From the CLEAR Outcomes Trial

Randomised trial in 13,970 peopleBempedoic acid

Frontiers in Nutrition8 Aug

Frequency of adding salt to foods, metabolic signature, and the risk of extracoronary atherosclerotic vascular disease progression

Cohort study of 495,291 peoplePopulations

The Lancet Diabetes & Endocrinology21 Jun

Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials

Randomised trial in 10,142 peopleCanagliflozin

American Heart Journal24 Jun

Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)--a randomized placebo-controlled trial

Study protocolCanagliflozin